BLU

Why Is Bellus Health (BLU) Stock Up 98% Today?

By William White, InvestorPlace Writer Apr 18, 2023

Bellus Health (BLU) stock is taking off on Tuesday after the company announced a $2 billion acquisition deal with GSK (GSK).

By William White, InvestorPlace Writer Apr 18, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders will want to keep an eye on Tuesday!

By William White, InvestorPlace Writer Dec 13, 2021

BELLUS Health (BLU) stock is rocketing higher on Monday and it's all thanks to data from a Phase 2b clinical trial of BLU-5937.

By Josh Enomoto, InvestorPlace Contributor Oct 14, 2021

With a new year fast approaching, these biotech penny stocks may benefit from the shifting winds in the broader healthcare market.

By Mark Putrino, CMT Mar 11, 2021

These penny stocks have more than just a low price point. They have Wall Street analysts backing up those prices with high price targets.

By Chris MacDonald, InvestorPlace Contributor Feb 18, 2021

Penny stocks like BLU stock and OBSV stock are gaining traction with retail investors, especially as analyst sentiment heats up.